Skip Navigation



Journal of the National Cancer Institute Advance Access published online on August 26, 2008
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djn263
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/17/1193    most recent
djn263v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Eng, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eng, C.
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

EDITORIAL

SDHB—A Gene for All Tumors?

Charis Eng

Affiliation of author: Genomic Medicine Institute, Lerner Research Institute and Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH; Department of Genetics and CASE Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH

Correspondence to: Charis Eng, MD, PhD, Genomic Medicine Institute, Cleveland Clinic, 9500 Euclid Ave, NE-50, Cleveland, OH 44195 (e-mail: engc@ccf.org).

The first 150 words of the full text of this article appear below.

Succinate dehydrogenase (SDH) or mitochondrial complex II, comprising four subunits (A–D) in the inner mitochondrial membrane, lies at the crossroads of electron transport and the Krebs tricarboxylic acid cycle (1). SDH, whose subunits are encoded by autosomal genes, catalyzes the conversion of succinate to fumarate. In turn, the fumarate to malate conversation is catalyzed by fumarate hydratase (FH). It is well documented that germline homozygous or compound heterozygous mutations of SDH genes (typically SDHA) and of genes encoding other mitochondrial complexes cause a group of recessive syndromes (eg, Leigh syndrome) that are characterized by relatively severe encephalomyelopathy, myopathy, cardiomyopathies, and/or hepatopathies, typically resulting in death in childhood (1). Similarly, germline homozygous or compound heterozygous mutations in FH also result in severe neurodegeneration and early death. Thus, it came as a surprise to both those with interest in mitochondrial metabolism and the oncology community when germline . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Germline SDHB Mutations and Familial Renal Cell Carcinoma
Christopher Ricketts, Emma R. Woodward, Pip Killick, Mark R. Morris, Dewi Astuti, Farida Latif, and Eamonn R. Maher
J Natl Cancer Inst 2008 100: 1260-1262. [Abstract] [Full Text] [PDF]

In This Issue
J Natl Cancer Inst 2008 100: 1191. [Extract] [Full Text] [PDF]